iOS app Android app

Drugs and Therapies

Biologics: The Case for 13 or More Years of Data Exclusivity

Pat Choate | Posted 05.25.2011 | Technology
Pat Choate

The United States will only realize this potential and remain the global leader in medical innovation if we maintain a strong environment for investment in the newest wave - biopharmaceuticals, also known as biologics.